11
SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors
Condition(s):NSCLC Stage IVLast Updated:May 24, 2022Recruiting
First Line Treatment: 7547 Clinical Trials, Page 2 of 755
Hide Studies Not Open or Pending
12
Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL
Condition(s):Acute Lymphoblastic Leukemia, Adult; Ph+ ALL; Newly DiagnosedLast Updated:December 1, 2022Active, not recruiting
13
Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC
Condition(s):First-line Treatment; Advanced Colorectal CancerLast Updated:October 25, 2021Recruiting
14
Gefitinib With Anlotinib in Advanced Non-squamous NSCLC Patients With Uncleared Plasma ctDNA EGFRm After First-line Treatment With Gefitinib
Condition(s):Non-small Cell Lung Cancer; EGFR Gene MutationLast Updated:April 24, 2020Unknown status
15
The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)
Condition(s):Esophageal Cancer; ToxicityLast Updated:May 31, 2017Completed
16
Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United Kingdom
Condition(s):MelanomaLast Updated:August 6, 2019Completed
17
HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer
Condition(s):First-line Treatment of Advanced Pancreatic CancerLast Updated:June 29, 2023Recruiting
18
Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC
Condition(s):Papillary Renal Cell Carcinoma Type 2Last Updated:August 29, 2022Recruiting
19
A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
Condition(s):Colorectal CancerLast Updated:August 21, 2008Completed
20
A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
Condition(s):BRAF V600E Mutation Positive; Metastatic Colorectal CancerLast Updated:January 25, 2023Completed